Patents by Inventor Masashi Takahara

Masashi Takahara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140073050
    Abstract: Activated antigen-presenting cells that can induce immunocytes including disease antigen-specific CD8+ CTLs and/or ?? T cells efficiently in vivo and/or in vitro, a medical composition comprising the activated antigen-presenting cells, a treatment and prevention method using the activated antigen-presenting cells, and an induction method of immunocytes including disease antigen-specific CTLs and/or ?? T cells induced using the activated antigen-presenting cell, immunocytes induced by the above-noted method, a medical composition comprising the immunocytes, and a treatment and prevention method using the immunocytes are provided. By co-pulsing antigen-presenting cells with bisphosphonate in addition to the pulse with a disease antigen, the ratio of disease antigen-specific CD8+ CTLs and/or ?? T cells and the number of the disease antigen-specific CD8+ CTLs and the ?? T cells can be increased, compared with the case where the co-pulse with bisphosphonate is not carried out.
    Type: Application
    Filed: November 12, 2013
    Publication date: March 13, 2014
    Applicant: MEDINET CO., LTD.
    Inventors: Mie NIEDA, Manami ISOGAI, Masashi TAKAHARA, Andrew NICOL
  • Patent number: 8609410
    Abstract: Activated antigen-presenting cells that can induce immunocytes including disease antigen-specific CD8+ CTLs and/or ?? T cells efficiently in vivo and/or in vitro, a medical composition comprising the activated antigen-presenting cells, a treatment and prevention method using the activated antigen-presenting cells, and an induction method of immunocytes including disease antigen-specific CTLs and/or ?? T cells induced using the activated antigen-presenting cell, immunocytes induced by the above-noted method, a medical composition comprising the immunocytes, and a treatment and prevention method using the immunocytes are provided. By co-pulsing antigen-presenting cells with bisphosphonate in addition to the pulse with a disease antigen, the ratio of disease antigen-specific CD8+ CTLs and/or ?? T cells and the number of the disease antigen-specific CD8+ CTLs and the ?? T cells can be increased, compared with the case where the co-pulse with bisphosphonate is not carried out.
    Type: Grant
    Filed: September 5, 2006
    Date of Patent: December 17, 2013
    Assignee: Medinet Co., Ltd.
    Inventors: Mie Nieda, Manami Isogai, Masashi Takahara, Andrew Nicol
  • Publication number: 20090104161
    Abstract: Activated antigen-presenting cells that can induce immunocytes including disease antigen-specific CD8+ CTLs and/or ?? T cells efficiently in vivo and/or in vitro, a medical composition comprising the activated antigen-presenting cells, a treatment and prevention method using the activated antigen-presenting cells, and an induction method of immunocytes including disease antigen-specific CTLs and/or ?? T cells induced using the activated antigen-presenting cell, immunocytes induced by the above-noted method, a medical composition comprising the immunocytes, and a treatment and prevention method using the immunocytes are provided. By co-pulsing antigen-presenting cells with bisphosphonate in addition to the pulse with a disease antigen, the ratio of disease antigen-specific CD8+ CTLs and/or ?? T cells and the number of the disease antigen-specific CD8+ CTLs and the ?? T cells can be increased, compared with the case where the co-pulse with bisphosphonate is not carried out.
    Type: Application
    Filed: September 5, 2006
    Publication date: April 23, 2009
    Inventors: Mie Nieda, Manami Isogai, Masashi Takahara, Andrew Nicol